Quick Answer
VYCOR MEDICAL INC reported Research And Development Expense of $10.0 thousand for the year ending 2025.
- VYCOR MEDICAL INC showed a decrease of -35.0% in Research And Development Expense from 2024 to 2025.
- This data is from VYCOR MEDICAL INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2010 to 2025), VYCOR MEDICAL INC's Research And Development Expense has declined by 34.5%.
- Historical annual values: Fiscal year 2025: $10.0 thousand | Fiscal year 2024: $15.3 thousand | Fiscal year 2023: $22.6 thousand | Fiscal year 2021: $15.2 thousand | Fiscal year 2017: $3.0 thousand | Fiscal year 2016: $4.7 thousand | Fiscal year 2015: $71.5 thousand | Fiscal year 2014: $69.1 thousand | Fiscal year 2013: $53.5 thousand | Fiscal year 2012: $126.0 thousand | Fiscal year 2011: $115.7 thousand | Fiscal year 2010: $15.2 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: